Results 201 to 210 of about 49,034 (223)

Accurate classification of BRCA1 variants with saturation genome editing

Nature, 2018
Gregory M Findlay, Joseph D Janizek, Lea M Starita   +2 more
exaly  

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer

Nature Reviews Clinical Oncology, 2016
Angela George, Susana Banerjee
exaly  

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Lancet, The, 2010
Andrew N J Tutt, Mark E Robson, Susan M Domchek   +2 more
exaly  

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Lancet, The, 2010
Michael Friedlander, Clare L Scott, Ana Oaknin   +2 more
exaly  

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

Lancet, The, 2000
Steven A Narod, Mark E Robson, Ketil R Heimdal   +2 more
exaly  

Family Physicians and Referrals of Low-risk Women for BRCA1/2 Genetic Services

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Is there more to BARD1 than BRCA1?

Nature Reviews Cancer, 2006
Irmgard Irminger-Finger
exaly  

BRCA screening.

The Medical letter on drugs and therapeutics, 2007
openaire   +1 more source

Multi-Gene BRCA Testing Identifies Mutations Other than BRCA Variants

Oncology Times, 2015
openaire   +1 more source

Breast Cancer (BRCA)

2012
openaire   +1 more source